ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,789.30
0.38%
S&P ASX All Technology
3,128.40
0.25%
Brent Oil
85.54
0.15%
US Dollar vs AUD
1.50976
0.41%
Bitcoin
62,062.17
0.73%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Vistin Pharma Asa (0RAM) Share Price

Vistin Pharma Asa

Vistin Pharma Asa (0RAM)

LSE
11.25
0.00
(0.00%)
Closed 28 June 1:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
11.25
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
11.25 52 Week Range 11.25
Market Cap
498.881M
Previous Close
11.25
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,262
Shares Outstanding
44,345,000
Dividend Yield
-
PE Ratio
10.93
Earnings Per Share (EPS)
1.03
Revenue
438.33M
Net Profit
45.64M

About Vistin Pharma Asa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.vistin.com
Headquarters
Oslo, Nor
Founded
1970
Vistin Pharma Asa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0RAM. The last closing price for Vistin Pharma Asa was kr11.25. Over the last year, Vistin Pharma Asa shares have traded in a share price range of kr 11.25 to kr 11.25.

Vistin Pharma Asa currently has 44,345,000 shares in issue. The market capitalisation of Vistin Pharma Asa is kr498.88 million. Vistin Pharma Asa has a price to earnings ratio (PE ratio) of 10.93.

0RAM Latest News

More News

Ex dividend NOK 0.50 today

Ex dividend NOK 0.50 today The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 05.06.2024.

05 June 2024
UK Regulatory

Vistin Pharma ASA: Minutes from the annual general meeting 2024

Vistin Pharma ASA: Minutes from the annual general meeting 2024 Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held...

23 May 2024
UK Regulatory

Disclosure of voting rights at AGM in Vistin Pharma ASA

Disclosure of voting rights at AGM in Vistin Pharma ASA Oslo, Norway, 23 May 2024 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 23th of May, the Company's...

23 May 2024
UK Regulatory

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024 Oslo, Norway, 30 April 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin...

30 April 2024
UK Regulatory

Vistin Pharma ASA: Annual Report 2023

Vistin Pharma ASA: Annual Report 2023 Oslo, Norway, 24 April 2024 Please find attached the Annual Report for 2023 for Vistin Pharma ASA. There are no material changes in the financial statements...

25 April 2024
UK Regulatory

Vistin Pharma ASA: First quarter 2024 financial results

Vistin Pharma ASA: First quarter 2024 financial results Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in...

24 April 2024
UK Regulatory

Vistin Pharma ASA: Invitation to Q1 2024 conference call

Vistin Pharma ASA: Invitation to Q1 2024 conference call Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will...

16 April 2024
UK Regulatory

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of...

23 March 2024
UK Regulatory
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10011.2511.2511.25600011.25DE
40011.2511.2511.25400011.25DE
120011.2511.2511.25326211.25DE
260011.2511.2511.25198911.25DE
520011.2511.2511.25211211.25DE
1560011.2511.2511.25175511.25DE
2600011.2511.2511.25236411.25DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IBGOIronbark Zinc Limited
AUD 0.002
(100.00%)
1.25M
TKMOTrek Metals Limited
AUD 0.002
(100.00%)
277.78k
TD1Tali Digital Limited
AUD 0.002
(100.00%)
505.06k
CLZClassic Minerals Limited
AUD 0.0015
(50.00%)
3.56M
VMLVital Metals Limited
AUD 0.003
(50.00%)
400k
MCTMetalicity Ltd
AUD 0.001
(-50.00%)
1.28M
DOUDouugh Limited
AUD 0.002
(-33.33%)
241.67k
BPHOBBPH Energy Limited
AUD 0.002
(-33.33%)
1M
OAROAR Resources Limited
AUD 0.001
(-33.33%)
300k
AVEAvecho Biotechnology Limited
AUD 0.002
(-33.33%)
200k
ADNAndromeda Metals Limited
AUD 0.016
(-11.11%)
19.41M
IMUImugene Limited
AUD 0.054
(0.00%)
16.7M
SISSimble Solutions Limited
AUD 0.002
(-20.00%)
16.62M
SYASayona Mining Limited
AUD 0.037
(0.00%)
15.26M
CXOCore Lithium Ltd
AUD 0.094
(-5.05%)
14.9M

Discussion

View Full Feed
janice shell janice shell 3 minutes ago
They look pretty easy to make.
jonsmile jonsmile 3 minutes ago
And your here to “look out for us” lol

I’m a buyer next week for more many more
BMXI
janice shell janice shell 5 minutes ago
Me too. I've wondered from the start whether it needed to be adjusted. Seems a bit better now.
BoscoLives21 BoscoLives21 5 minutes ago
The 1812 Brewing Co. operates its wholly-owned brewery and two distinctive venues on the water in Watertown, N.Y. on the eastern shore of Lake Ontario. Multiple award-winner on several of its over a dozen beers and ales, sales and distribution continue to expand.
Large short interest had mani
KEGS
VeronicaFox VeronicaFox 5 minutes ago
Nonsense, are you disputing these numbers from the regulators?:

FINRA SHORT INTEREST: 0
https://otce.finra.org/otce/equityShortInterest

SECGov FAILURE TO DELIVER: 0
https://www.sec.gov/data/foiadocsfailsdatahtm

“The Misleading” – Daily Sho
KEGS
Ozie2bobthericher Ozie2bobthericher 6 minutes ago
Another badger on the loose. Show us your evidence. Please show anything that supports your claim ???
CDBT
janice shell janice shell 6 minutes ago
lol, it's not that bad. But he does sound as if he has a cold. Or laryngitis.
Ozie2bobthericher Ozie2bobthericher 6 minutes ago
Another badger on the loose. Show us your evidence. Please show anything that supports your claim ???
CDBT
hap0206 hap0206 8 minutes ago
Nah — its trump four years vs Biden four years— watch and weep
chen1992 chen1992 8 minutes ago
I spit my water out Trump was like, “I don’t know what he said, i don’t even think he knows what he said“ hahaha
TGLO
Gregg4 Gregg4 8 minutes ago
Yes everyday only Gregg on there
ESPR
Whalatane Whalatane 9 minutes ago
Ernie ...they had time to get the extra enrolled patients evaluated . The risk is that so many were dropping out therefore they needed to enroll more .
The danger is ...if enrollees are dropping out so much ...good luck getting OLC widely accepted .
I still hold some shares and will fo
ARDX
janice shell janice shell 9 minutes ago
He's going after the lies now. AHHHH, A SMILE!! He needs to do more of that.
delerious1 delerious1 10 minutes ago
If I was Biden's handler I would have CNN pick up his mike a lot
Mr. C Mr. C 11 minutes ago
Good for Delfin / $TGLO and LNG. Biden just lost the election in the first 15 minutes. They’re gonna switch him out maybe now

https://x.com/libsoftiktok/status/1806497217039282344?s=46&t=0G1C3kweqq00SqrZrh0yFg
TGLO
aheadofthecurve aheadofthecurve 11 minutes ago
"one more trigger"
RSPI
arizona1 arizona1 11 minutes ago
Biden sounds like he's got covid.
OncoJock OncoJock 11 minutes ago
My analysis using Better Investing's Stock Selection Guide Plus is telling me that HALO is a buy up to about $58.50 and a sell above about $103. Annual total return is projected at 19% over the next 5 years, well above the BI recommended target of 15%, which is the rate it takes to double your money
HALO
Homebrew Homebrew 11 minutes ago
Nugent scammer's behind this ticker! Yikes. Big red flag
CDBT
Susie924 Susie924 11 minutes ago
He looks shell shocked.
thistraderknowsall thistraderknowsall 12 minutes ago
ACH altcoin !!! Correct the $5.25 upgrade is working great!!! Congrats! Great news .. up we go!! FOMO MOASS..

ACH is in its way to $10 + run.
We rich!!!! EM switching to ACH!!! THANKS!!!
janice shell janice shell 12 minutes ago
Well... They say incumbent presidents usually do a poor job in their first debate... Obama did.

Okay, that's better: "Everything he said is a lie!"
arizona1 arizona1 13 minutes ago
And he isn't rebutting any of the convicted felon's lies. This is really horrible.

Your Recent History

LSE
0RAM
Vistin Pharma Asa
LSE
HA08
Citi Fun 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved